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Crosstalk between T and B cells is crucial for generating high-affinity, class-switched
antibody responses. The roles of CD4+ T cells in this process have been well-
characterised. In contrast, regulation of antibody responses by CD8+ T cells is
significantly less defined. CD8+ T cells are principally recognised for eliciting cytotoxic
responses in peripheral tissues and forming protective memory. However, recent findings
have identified a novel population of effector CD8+ T cells that co-opt a differentiation
program characteristic of CD4+ T follicular helper (Tfh) cells, upregulate the chemokine
receptor CXCR5 and localise to B cell follicles. While it has been shown that CXCR5+CD8+
T cells mediate the removal of viral reservoirs in the context of follicular-trophic viral
infections and maintain the response to chronic insults by virtue of progenitor/stem-like
properties, it is not known if CXCR5+CD8+ T cells arise during acute peripheral challenges
in the absence of follicular infection and whether they influence B cell responses in vivo in
these settings. Using the ovalbumin-specific T cell receptor transgenic (OT-I) system in an
adoptive transfer-immunisation/infection model, this study demonstrates that
CXCR5+CD8+ T cells arise in response to protein immunisation and peripheral viral
infection, displaying a follicular-homing phenotype, expression of cell surface molecules
associated with Tfh cells and limited cytotoxic potential. Furthermore, studies assessing
the B cell response in the presence of OT-I or Cxcr5-/- OT-I cells revealed that
CXCR5+CD8+ T cells shape the antibody response to protein immunisation and
peripheral viral infection, promoting class switching to IgG2c in responding B cells.
Overall, the results highlight a novel contribution of CD8+ T cells to antibody responses,
expanding the functionality of the adaptive immune system.
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The generation of high affinity, class-switched antibody
responses are important for immune defence against infection
and conferring host protection following immunisation.
Crosstalk between T and B cells is crucial for successful
antibody responses. A subset of CD4+ T cells known as T
follicular helper (Tfh) cells are primarily responsible for
interacting with responding B cells and mediating their
selection, survival, affinity maturation and class-switch
recombination (1, 2). Tfh cells express the follicular-homing
chemokine receptor CXCR5, while concurrently downregulating
the T-zone homing receptor CCR7, driving their localisation
towards CXCL13-rich follicles where they can interact directly
with responding B cells (3–6). Interestingly, other immune cell
subsets, including invariant natural killer T cells and CD4+
regulatory T cells, have also been reported to co-opt a
differentiation program characteristic of the Tfh lineage (7–9).
In doing so, they acquire a similar phenotype to Tfh cells,
including expression of CXCR5, and migrate to follicles where
they regulate B cell responses. Notably, in 2007, a population of
CXCR5+CD8+ T cells with Tfh-like characteristics was identified
in human tonsils (10). Subsequent investigations identified
CXCR5+CD8+ T cells as a specific subset that also co-opts the
Tfh differentiation pathway and migrates to follicles in response
to CXCR5-mediated migratory cues (11–13). In the context of
chronic follicular-trophic viral infections, CXCR5+CD8+ T cells
control infection through killing infected cells in the follicular
microenvironment (11), eliminating viral reservoirs and
maintaining the response against chronic infection (13).
Furthermore, CXCR5+CD8+ T cells have been identified in
tumours and tumour draining lymph nodes (14–16). In these
settings they have been reported to exhibit stem-like properties,
presenting as promising targets for anti-PD-1 therapy and
displaying superior anti-tumour functionality compared to
their CXCR5- counterparts.
While the cytotoxic functions of CXCR5+CD8+ T cells have
been described in the setting of chronic infection, important
questions regarding the context-specific functionality of these
cells remain. Specifically, whether CXCR5+CD8+ T cells participate
in humoral immunity requires further investigation. Indeed, in
vitro studies have demonstrated that CXCR5+CD8+ T cells can
support B cell antibody production (10, 17–19). Additionally,
studies exploring settings where CXCR5+CD8+ T cell
differentiation is enhanced have found an associated increase in
self-reactive antibody responses, indicating CXCR5+CD8+ T cells
promote autoimmune humoral immunity (20, 21). However,
whether CXCR5+CD8+ T cells participate in physiological
humoral immunity in vivo is yet to be established. Therefore, in
the present study, using models where there is an absence of
infection in the follicular microenvironment, we investigated the
role of CXCR5+CD8+ T cells in humoral immune responses in vivo
in settings where there is no necessity for cytotoxic function within
the follicular microenvironment. We show that CXCR5+CD8+ T
cells develop in response to protein immunisation and influenza A
virus (IAV) infection, displaying a follicular-homing phenotype
and surface expression profile similar to Tfh cells, as well asFrontiers in Immunology | www.frontiersin.org 2exhibiting diminished cytotoxic potential. In addition, we
demonstrate that these cells shape antibody responses, promoting
IgG2c class switching in responding B cells in these settings. Taken
together, these data show that in addition to their previously
described cytotoxic functions in response to infections in the
follicular microenvironment, CXCR5+CD8+ T cells also shape
antibody responses in vivo.MATERIALS AND METHODS
Mice
C57BL/6 and Ly5.1 mice were purchased from the Animal
Resource Centre (WA, Australia). OT-I mice were purchased
from the Walter and Eliza Hall animal facility (Kew: VIC,
Australia) and crossed with Ly5.1 mice at the University of
Adelaide animal facility to obtain OT-I CD45.1/CD45.2
(CD45.1/2) mice. CXCR5-deficient (Cxcr5-/-) mice were bred at
the University of Adelaide animal facility and crossed to OT-I
mice to generate Cxcr5-/- OT-I mice. Transgene status of OT-I
and Cxcr5-/- OT-I mice was determined by flow cytometric
analysis of TCR Va2 expression. Interferon-gamma-deficient
(B6.Ifng-/-) mice were obtained from the Queensland Institute of
Medical Research (QIMR) Berghofer animal facility. Age
matched, female mice at 6-16 weeks of age were used in
experiments. Experiments were conducted under approval
from the University of Adelaide Animal Ethics Committee.
Immunisations, Infections, Adoptive Cell
Transfers, and Treatments
Ovalbumin precipitated in alum (OVA/alum) was prepared by
diluting a 1 mg/mL solution of ovalbumin (Sigma-Aldrich) in
PBS to 0.5 mg/mL in a-minimal essential media (aMEM, Gibco)
supplemented with 25 mM HEPES (Gibco). An equal volume of
a 10% w/v solution of aluminium potassium sulphate (BDH
chemicals Ltd) prepared in MilliQ water was then added and the
resulting solution was adjusted to pH of 6.5 with 1 M sodium
hydroxide and 1 M hydrochloric acid. The solution was then
washed extensively with PBS by centrifugation at 500g for 10min
at 4°C. The precipitated OVA/alum was resuspended at 0.5 mg/
mL in PBS and 200 μL (100 μg) was injected into mice
intraperitoneally (i.p). The HKx31 (x31) and HKx31-OVA
(x31-OVA) influenza A viruses (IAVs) have been described
previously (22). Virus stocks for infections were grown in
chicken eggs. For IAV infections, mice were anesthetised with
60 μg/g of pentabarbitone (ilium) in PBS i.p and a dose of 10
TCID50 of x31 or x31-OVA diluted in PBS was administered
intranasally in a volume of 32 μL. OT-I and Cxcr5-/- OT-I cells
were negatively isolated from spleens using the EasySep™Mouse
Naïve CD8+ T Cell Isolation Kit (STEMCELL Technologies), as
per the manufactures guidelines, at routinely >90% purity. For
experiments in the OVA/alum model, 2x105 OT-I cells were
transferred i.v. in 200 μL of PBS a day prior to immunisation,
either from WT OT-I or Cxcr5-/- OT-I mice. This was the same
for the x31-OVA model except 1x104 OT-I cells were transferred
instead. To deplete CD8+ T cells, mice were treated with 100 μgJuly 2021 | Volume 12 | Article 626199
Tyllis et al. CXCR5+CD8+ T Cells Shape Antibody Responsesof aCD8b (clone 53-5.8, Bio X cell) in 200 μL PBS i.p 4 days prior
to IAV infection and on day 4 (and again on day 12 where
required) post-infection. Control mice were treated with an
equivalent quantity of rat g-globulin (Rockland).
Flow Cytometry
Single-cell suspensions were prepared by pressing spleens and
mediastinal lymph nodes through 70μm nylon filters
(FALCON). Red blood cells were lysed by incubating spleen
cell suspensions in red cell lysis buffer (139.5 mM NH4Cl, 17
mM Tris-HCl, pH 7.2) for 5 minutes at 37°C. Cells were stained
in 96-well round-bottom trays (Corning) at 2x106 cells/well. For
intracellular cytokine staining, cells were incubated in complete
IMDM containing 20 ng/mL phorbol 12-myristate 13-acetate
(PMA, Sigma-Aldrich) and 1 μM Ionomycin (Life Technologies)
for a total of 4 hrs at 37°C with addition of 1/1500 GolgiPlug
(Brefeldin A, BD) and 1/1500 GolgiStop (containing monensin,
BD) for the final 3hrs, before staining. OT-I cells were stimulated
with SIINFEKL peptide (InvivoGen) at 1 μg/mL in IMDM for
4hrs in the presence of GolgiPlug and GlogiStop for the final
3hrs. Cells were washed with PBS and stained with Near Infrared
Fixable Viability Dye (Life Technologies) diluted 1/1,000 in PBS
for 15min at room temperature (RT). Subsequently, cells were
washed in FACS buffer (PBS containing 1% bovine serum albumin
and 0.04% sodium azide) then blocked with 200 mg/mL mouse g-
globulin (Rockland) for 10-15 minutes at RT. For staining
immunoglobulin isotypes, cells were blocked with 200 mg/mL rat
g-globulin (Rockland) for 10-15 minutes at RT. The following
steps were performed at 4°C unless otherwise stated. For CXCR5
staining, cells were incubated with purified a CXCR5 (BD, clone
2G8) for 1 h, washed with FACS buffer then incubated with
fluorophore-labelled secondary antibody in the presence of mgg
(200 mg/mL) and normal mouse serum (NMS) (1%) for 30-40min
before washing in FACS buffer and blocking with 200 mg/mL rat g-
globulin (Rockland) for 10-15 minutes. Cells were then stained
with fluorophore-labelled and biotinylated antibodies (BD; CD8
(53.6-7), CD4 (GK1.5), CD44 (IM7), CD45.1 (A20), CD45.2
(104), B220 (RA3-6B2), KLRG1 (2F1), CD127 (SB/199), Tim-3
(5D12/TIM-3), CD138 (281-2), IgD (11-26c.2a): eBioscience;
ICOS (C398.4A), PD-1 (J43), BTLA (8F4): BioLegend; T/B Cell
Act. Marker (GL7), Ly108 (330-AJ)) for 20 minutes and washed
with PBS containing 0.04% sodium azide. For staining
intracellular cytokines and immunoglobulin isotypes, cells were
incubated in Cytofix/Cytoperm (BD) for 25-30minutes, washed in
Permwash (BD) and incubated with fluorophore-labelled and
biotinylated antibodies (BD; IFNg (XMG1.2), TNFa (MP6-
XT22), GzmB (GB11), IgG2a/c (5.7), eBioscience; IgM (eB121-
15F9), IgG1 (M1-14D12)) for 25-30 minutes in Permwash. For
transcription factor staining, cells were incubated in 100 μL of
freshly prepared FOXP3 Fixation/Permeabilisation Solution
(Invitrogen) for 25-30 minutes at RT in the dark, before
washing in FOXP3 Permeabilisation Buffer (Invitrogen) and
staining with fluorophore-labelled antibodies [BD; TCF-1 (S33-
966)] in Permeabilisation Buffer for 25-30 minutes. For detection
of biotinylated antibodies, cells were incubated with fluorophore-
labelled streptavidin for 20 minutes. After washing in PBS withFrontiers in Immunology | www.frontiersin.org 30.04% sodium azide, cells were resuspended in PBS with 1%
paraformaldehyde and stored at 4°C in the dark. Acquisition
was performed on a BD LSR II, BD FACSAria or BD LSR
Fortessa and analysed with FlowJo Software (BD).
Enzyme-Linked Immunosorbent
Assays (ELISAs)
For analysis of x31-specific antibodies in the serum of mice
infected with x31/x31-OVA, concentrated x31 (~70x106
TCID50) was diluted 1/200 in 0.1 M sodium bicarbonate and
incubated overnight at RT in 96-well flat-bottom EIA/RIA high-
binding plates (Corning). The plates were then washed with PBS
containing 0.05% Tween (AMRESCO) (PBS/Tween) and blocked
with PBS containing 2% skim milk for 2 h at RT. Plates were
washed with PBS/Tween and then incubated with serum dilutions
prepared in PBS for 2 h at RT before washing with PBS/Tween and
incubation with anti-mouse isotype-specific horseradish
peroxidase (HRP) conjugated antibodies (SouthernBiotech; IgM,
IgG, IgG1, IgG2c, IgG3) diluted in PBS containing 2% skim milk
for 2 h at RT. After washing with PBS/Tween, the plates were
developed by adding 1xTMB substrate solution (Invitrogen) for
10-20 minutes in the dark. The reaction was stopped by addition
of 1 M orthophosphoric acid and absorbance was measured at 450
nM on a Biotrack II plate reader (Amersham BioScience).Ex Vivo Cytotoxicity Assay
E0771-mCherry and E0771-GFP-OVA cells were grown in
DMEM with 10% FCS and 100 U/mL Penicillin/Streptomycin,
harvested and stained with Cell Proliferation Dye eFlour670
(eBioscience) and carboxyflourescien succinimidyl ester (CFSE,
Molecular Probes) respectively, according to the manufacture’s
guidelines. Subsequent to dye staining, cells were washed twice in
complete IMDM and resuspended to a concentration of 2.0x105
cells/mL in complete IMDM. Equal volumes of the dye-labelled
E0771-mCherry and E0771-GFP-OVA cells were mixed and 100
μL of the resulting cell suspension was then distributed to the
appropriate wells of a 96-well flat-bottom plate (20,000 cells/well
total), followed by incubation for 4 hours at 37°C in 5% CO2.
Effector CXCR5+ and CXCR5- OT-I cells (pre-gated on live,
CD4-B220-CD8+TCRb5.1+CD44+ cells) were FACS-sorted from
the spleens of OT-I mice immunised seven days earlier with
OVA/alum i.p. Sorted OT-I cells were incubated with E0771 cells
at effector cell to target cell ratios of 0.5:1, 1:1 and 5:1 for 12 hours
at 37°C in 5% CO2. The supernatant was then transferred to a
new 96 well V-bottom plate. Wells were then washed in 50 μL of
1X PBS that was pooled with the supernatant. Adherent E0771
cells were harvested by incubation in 50 μL of trypsin/EDTA for
5 minutes at room temperature. The reaction was neutralised
with 100 μL of supernatant obtain previously and cells were
pooled into the 96 well V-bottom plate. Cells were then subjected
to flow cytometric analysis to assess killing of E0771 target cells.
To quantify cytotoxic activity, the following formulae were
utilised:
%  Specific killing = ½%  CFSE+  E0771 cells that were positive for LIVE=DEAD viability dye staining−
½%  670+E0771 cells that were positive for LIVE=DEAD  viability dye staining :July 2021 | Volume 12 | Article 626199
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Data were analysed in GraphPad Prism 8 & 9. Statistical tests
were two-sided and applied as detailed in the figure legends.
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.RESULTS
To date, CXCR5+CD8+ T cells have only been shown in chronic
infection, cancer and autoimmunity, all settings where there is
antigen persistence. To determine if CXCR5+CD8+ T cells are
also generated in response to acute challenges that do not
establish chronic infection in the follicular microenvironment,
MHC class I-restricted, ovalbumin-specific, CD8+ T cells (OT-I
cells) were utilised in the context of adoptive transfer-
immunisation/infection strategies. Isolated naïve OT-I cells were
transferred intravenously into WT C57Bl/6 mice that were
subsequently immunised intraperitoneally with ovalbumin
precipitated in alum (OVA/alum) or infected intranasally with a
recombinant x31 IAV strain expressing the ovalbumin-derived
SIINFEKL peptide (x31-OVA). Flow cytometry assessing the
response to OVA/alum in the spleen 7 days post-immunisation
and x31-OVA in the mediastinal lymph node (mLN) 8 days post-
infection, demonstrated that ~60% and ~45% of endogenous
CD44hiCD8+ T cells expressed CXCR5, respectively, compared
to naïve CD44loCD8+ T cells which displayed minimal positivity
for CXCR5 (Figures 1A, B). Furthermore, analysis of the antigen-Frontiers in Immunology | www.frontiersin.org 4specific OT-I cells revealed that ~45% and ~6.5% were expressing
CXCR5 in response to OVA/alum and x31-OVA, respectively
(Figures 1A, B). These results demonstrate that CXCR5+CD8+ T
cells arise in acute responses in the absence of infection in the
follicular microenvironment following protein immunisation and
peripheral viral infection.
To explore possible functions of CXCR5+CD8+ T cells
identified in these settings, activated CD44hi CXCR5+ and
CXCR5- OT-I cells were compared for expression of key
cytokines and cell surface molecules (Figures 2A–M).
Intracellular cytokine staining demonstrated that CXCR5+CD8+
T cells expressed less IFNg than CXCR5-CD8+ T cells in response
to OVA/alum and x31-OVA (Figures 2A, B), although this small
difference is unlikely to be physiologically relevant. CXCR5+CD8+
T cells produced less TNFa than their CXCR5- counterparts in
response to OVA/alum while CXCR5+ and CXCR5-CD8+ T cells
expressed similar levels of TNFa in response to x31-OVA
(Figures 2A, B). In both models, CXCR5+CD8+ T cells had
significantly reduced levels of granzyme B (GzmB) than CXCR5-
CD8+ T cells (Figures 2C, D). Furthermore, in an ex vivo
cytotoxicity assay, CXCR5+CD8+ T cells generated in response
to OVA/alum were substantially less potent cytotoxic effector
cells than their CXCR5- counterparts (Figure 2E). In both
models, it was apparent that CXCR5+CD8+ T cells are enriched
for cells with a KLRG1-CD127- surface phenotype (Figures 2F,
G), which in the OVA/alum model are predominantly early
effector cells. In addition, CXCR5+CD8+ T cells in both models
also displayed a Tim-3loTCF-1hi signature indicative of aA
B
FIGURE 1 | CXCR5+CD8+ T cells are generated in acute settings in the absence of follicular infection following protein immunisation and IAV challenge. Isolated,
congenically marked (CD45.1/2) OT-I cells were transferred i.v into C57BL/6 mice that were then (A) immunised with OVA/alum intraperitoneally or (B) infected with
x31-OVA intranasally. Flow cytometry of (A) spleen cells on day 7 post-immunisation with OVA/alum and (B) mLN cells on day 8 post-infection with x31-OVA,
assessing CXCR5 expression on the indicated cell populations. Data are representative of at least three independent experiments with at least 4 mice. Data were
analysed by a repeated measures one-way ANOVA. Mean ± SEM. **p < 0.01, ****p < 0.0001.July 2021 | Volume 12 | Article 626199







FIGURE 2 | CXCR5+CD8+ T cells generated in response to OVA/alum and IAV are distinct from their CXCR5- counterparts. Isolated congenically marked (CD45.1/
2) OT-I cells were transferred i.v into C57BL/6 mice that were immunised with OVA/alum i.p or infected with x31-OVA i.n the following day. On day 7 post-
immunisation and day 8 post-infection, the spleens (OVA/alum) and mLNs (x31-OVA) were harvested and analysed by flow cytometry. (A, B) IFNg and TNFa
expression by CXCR5+ and CXCR5- OT-I cells and naïve CD8+ T cells following (A) OVA/alum and (B) x31-OVA. (C, D) Granzyme B (GzmB) expression by CXCR5+
and CXCR5- OT-I cells and naïve CD8+ T cells following (C) OVA/alum and (D) x31-OVA. (E) Ex vivo cytotoxicity assay assessing the specific killing of CXCR5+ and
CXCR5- OT-I cells FACS-sorted from the spleens of mice immunised i.p with OVA/alum 7 days prior. (F, G) CD127 and KLRG1 expression by CXCR5+ and CXCR5-
OT-I cells following (F) OVA/alum and (G) x31-OVA. (H, J) Tim-3 expression by CXCR5+ and CXCR5- OT-I cells and naïve CD8+ T cells following (H) OVA/alum and
(J) x31-OVA. (I, K) TCF-1 expression by CXCR5+ and CXCR5- OT-I cells, TFH, Pre-TFH, Naïve CD8+ T cells and B220+ B cells following (I) OVA/alum and (K) x31-
OVA. (L, M) Expression of ICOS, BTLA, PD-1 and Ly108 by CXCR5+ and CXCR5- OT-Is, TFH, Pre-TFH and Naïve CD8+ T cells following (L) OVA/alum and
(M) x31-OVA. Refer to Figure 1 for gating of CXCR5+ and CXCR5- OT-I cells and Naïve CD8+ T cells. Refer to Supplementary Figure 1A for gating of TFH and
Pre-TFH populations. (A–D, F–M) Data are representative of at least two independent experiments with at least 4 mice. (E) Data are representative of two
independent experiments with 3 mice. (A–D, F–M) Data were analysed by paired t-tests or (E) two-way ANOVA with Bonferroni’s multiple comparison test to
compare CXCR5+ and CXCR5- OT-I cells. (A–D, F–M) Mean ± SEM or (E) Mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.Frontiers in Immunology | www.frontiersin.org July 2021 | Volume 12 | Article 6261995
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profile of CXCR5+CD8+ T cells identified in LCMV infection
(23). Further profiling identified that CXCR5+CD8+ T cells
express higher levels of Tfh-associated cell surface molecules,
including ICOS, BTLA and Ly108 in response to OVA/alum and
x31-OVA than that present on CXCR5-CD8+ T cells (Figures 2L,
M). PD-1 levels were slightly higher on CXCR5+CD8+ T cells in
OVA/alum while they were slightly lower between CXCR5+ and
CXCR5- CD8+ T cells in x31-OVA (Figures 2L, M). Overall,
these results indicate that CXCR5+CD8+ T cells are generated in
acute settings in response to protein immunisation and IAV and
are phenotypically distinct from their CXCR5- counterparts,
highlighting the potential for differing functionalities.
Together, the apparent follicular-homing characteristics, Tfh-
like surface phenotype and reduced cytotoxic potential led us to
hypothesize that CXCR5+CD8+ T cells could support B cell
responses in vivo. Interestingly, a previous study in the OVA/
alum immunisation model demonstrated that CD8+ T cell-derived
IFNg skewed switching patterns in responding B cells from IgG1 to
IgG2a (24). To determine whether CXCR5+CD8+ T cells influence
class switching in B cells in response to OVA/alum, wild type (WT)
or Cxcr5-/- OT-I cells were transferred into separate hosts which
were then immunised with OVA/alum and the response in the
spleen was assessed 7 days later (Figure 3A). Transfer of WT or
Cxcr5-/- OT-I cells did not affect IFNg production in endogenous
CD4+ T cells and did notmodulate the frequency of Tfh or Th1 cells
(Supplementary Figures 1B–F). Within the B cell compartment,
transfer of OT-I cells did not influence the numbers of
CD138+B220int antibody secreting cells (ASCs) (Figure 3C) or
B220+IgD-GL7+ germinal centre B (GCB) cells (Figure 3H).
However, an OT-I cell-dependent, ASC-restricted, induction of
IgG2c class switching, which appeared to be at the expense of class
switching to IgG1, was apparent that was dependent on Cxcr5
expression by the transferred OT-I cells (Figures 3B–F). There was
no apparent role for OT-I cells in regulating IgG2c class switching
in GCB cells (Figures 3G–K). Importantly, loss of CXCR5 onOT-I
cells did not greatly affect their capacity to respond to OVA/alum
immunization and these cells efficiently produced IFNg
(Supplementary Figures 1G, H). Collectively, these data
demonstrate that CXCR5+CD8+ T cells promote IgG2c class
switching in ASCs in response to protein immunisation, likely
through local delivery of IFNg to responding B cells.
To extend the finding that CXCR5+CD8+ T cells promote IgG2c
class switching in ASCs in the absence of chronic follicular
infection, we determined whether CXCR5+CD8+ T cells could
support B cell responses to IAV infection. Prior to specifically
investigating the role of CXCR5+CD8+ T cells, we assessed the
overall contribution of CD8+ T cells to the humoral immune
response against IAV by depleting CD8+ T cells with an antibody
against CD8b. Analysis of serum at day 8 post IAV infection
revealed that mice depleted of CD8+ T cells had similar levels of
x31-specific IgM (Figure 4A) and IgG1 (Figure 4D), slightly lower
levels of x31-specific IgG (Figure 4B) and IgG3 (Figure 4C), and
significantly reduced levels of x31-specific IgG2c (Figures 4E, F),
when compared to controls. This result was paralleled by a
reduction in the proportion of IgG2c class switched ASCs in theFrontiers in Immunology | www.frontiersin.org 6mLN in CD8b-depleted mice (Figures 4G–J). While the frequency
of total ASCs was slightly increased in CD8b-depleted mice
(Figure 4H), as removal of the CD8+ T cell compartment affects
the relative frequencies of the remaining cell populations, the total
number of ASC was unchanged (Figure 4I). With regard to the
cellularity of the IgG2c-switched ASC response, the frequency of
IgG2c-switched ASCs among live cells was unchanged between the
two groups (Figure 4K), while the reduced switching to IgG2c in
the ASC compartment led to an average ~25% decrease in the total
number of IgG2c-switched ASCs in CD8b-depleted mice (Figure
4L, Mean (Ctrl) = 472152, Mean (aCD8b) = 341128), although this
was not statistically significant. Interestingly, the GCB cell response
was significantly impaired in CD8b-depleted mice (Figures
4M–O), indicating CD8+ T cells support optimal induction of the
GCB cell response to IAV infection. This in turn lead to a
significant reduction in the cellularity of the IgG2c-switched GCB
cell response in CD8b-depleted mice (Figures 4Q, R), although the
frequency of IgG2c class switching within the GCB cell
compartment was unchanged (Figure 4P). Further assessment of
the humoral response at day 14 post IAV infection revealed that
x31-specific IgG2c levels in the serum of CD8b-depleted mice
recovered to that of the controls (Supplementary Figure 1I), while
the cellularity of the GCB cell response had also equilibrated
between the two groups (Supplementary Figures 1J, K). Overall,
we conclude that CD8+ T cells are required for optimal induction of
the early extrafollicular wave of IgG2c in the humoral immune
response against IAV.
Notably, IgG2c is the predominant isotype produced in
response to viral infection (26) and it is considered a highly
effective anti-pathogen isotype (27, 28). Class switching to IgG2c
is induced by IFNg (29) and requires the downstream
transcription factor T-bet (30). While the contribution of
follicular CD4+ T cell-derived IFNg to IgG2c class switching in
responding B cells is well-recognised (31), other cellular sources of
IFNg have also been reported to promote IgG2c class switching,
including gd T (32) cells, NKT cells (33) and CD4+ T-helper 1 cells
(34). Thus, to specifically investigate a role for CXCR5+CD8+ T
cells in mediating IgG2c class switching in response to IAV, we
transferred WT or Cxcr5-/- OT-I cells into B6.Ifng-/- mice, infected
the recipients with x31-OVA and harvested the mLNs on day 6
post-infection for flow cytometric analyses (Figure 5A). While
there was a basal level of IFNg-independent IgG2c class switching
in the no-transfer controls, transfer of OT-I cells substantially
enhanced class switching to IgG2c in ASCs (Figures 5B–E).
However, this effect was not observed when Cxcr5-/- OT-I cells
were transferred. Interestingly, in this setting, transfer ofWTOT-I
cells also significantly enhanced IgG2c class switching in the GCB
cell compartment on day 6 post-infection, an effect that was also
dependent on CXCR5 expression by OT-I cells (Figures 5F–I).
This result indicated that CXCR5+CD8+ T cells can promote
IgG2c class switching in the GCB cell compartment when the
ability to produce IFNg was restricted to adoptively transferred
CD8+ T cells, as is the case in B6.Ifng-/- recipients. Importantly,
there were no differences in IFNg production between WT and
Cxcr5-/- OT-I cells (Supplementary Figures 1L–N), indicating
that CXCR5-mediated migratory cues were required for OT-I cellsJuly 2021 | Volume 12 | Article 626199
Tyllis et al. CXCR5+CD8+ T Cells Shape Antibody Responsesto shape class switching in responding B cells, likely through local
delivery of IFNg to activated B cells. Using the same experimental
strategy, analysis of x31-specific IgG2c in the serum on day 8 post-
infection revealed that CXCR5 expression in transferred OT-I cellsFrontiers in Immunology | www.frontiersin.org 7was required for optimal induction of x31-specific IgG2c (Figure
5J). Overall, these results demonstrate that CXCR5+CD8+ T cells
shape the humoral response to peripheral viral infection,






FIGURE 3 | CD8+ T cells require CXCR5 expression to skew class switching from IgG1 to IgG2c in ASCs in response to OVA/alum. Congenically marked WT (CD45.1/2) or
Cxcr5-/- (CD45.2) OT-I cells (or PBS only for no transfer controls) were transferred i.v into separate B6.Ly5.1 (CD45.1) mice that were subsequently immunised with OVA/alum
i.p. and harvested on day 7 post-immunisation for analysis. (A) Schematic outline of the experiment. (B) Gating strategy used for identification of CD138+B220int ASCs in
spleens. Pre-gated on live, single cells. (C) Total number of ASCs. (D) Analysis of intracellular IgG1 and IgG2c in IgM- ASCs. (E, F) Frequency of (E) IgG1+ and (F) IgG2c+
ASCs among total ASCs. (G) Gating strategy used for identification of B220+IgD-GL7+ GCB cells in spleens. Pre-gated on live, single, B220+CD138- cells. (H) Total number of
GCB cells. (I) Analysis of intracellular IgG1 and IgG2c in total GCB cells. (J, K) Frequency of (J) IgG1+ and (K) IgG2c+ GCB cells among total GCB cells. (C, E, F, H, J, K)
Data are pooled from two independent experiments with a total of 6-10 mice per group. Data were analysed by ordinary one-way ANOVA. Mean ± SEM. *p < 0.05.July 2021 | Volume 12 | Article 626199
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FIGURE 4 | CD8+ T cells support induction of IgG2c responses against IAV. C57BL/6 mice were treated i.p. with either aCD8b or control antibody 4 days before
and on day 4 after i.n infection with x31 and harvested on day 8 post-infection. Levels of serum x31-specific (A) IgM, (B) IgG, (C) IgG3, (D) IgG1 and (E) IgG2c
assessed by ELISA. (F) Absorption summation (AbS) analysis of the x31-specific IgG2c ELISA data in (E). AbS is determined by adding the absorbance values from
all dilutions to obtain a single value for each biological replicate (25). (G) Gating strategy used for identification of CD138+B220int ASCs and IgG2c-switching in ASCs
in the mLN. Cells in the top panel were pre-gated on live, single cells. (H, I) Quantification of the ASC response by (H) frequency and (I) number. (J–L) Analysis of
the IgG2c+ ASC response by (J) proportion of total ASCs, (K) frequency of total live cells and (L) number. (M) Gating strategy used for identification of B220+IgD-
GL7+ GCB cells and IgG2c-switching in GCB cells in the mLN. Cells in the top panel were pre-gated on live, B220+CD138- cells. (N, O) Quantification of the GCB
cell response by (N) frequency and (O) number. (P–R) Analysis of the IgG2c+ GCB cell response by (P) proportion of total GCB cells, (Q) frequency of total live cells
and (R) number. (A–F) Data are pooled from two independent experiments with a total of 12 mice per group (Ctrl and aCD8b) or 3 mice (Naïve) and the absorbance
values for the ELISA data have been normalised to the average of the Ctrl group for each independent experiment prior to pooling the data. (H–L, N–R) Data are
pooled from three independent experiments with 17-19 mice per group. (A–E) Data were analysed by two-way ANOVA with Bonferroni’s multiple comparison test or
(F, H–L, N–R) unpaired t-tests. (F, H–L, N–R) Mean ± SEM or (A–E) Mean + SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.Frontiers in Immunology | www.frontiersin.org July 2021 | Volume 12 | Article 6261998







FIGURE 5 | CXCR5+CD8+ T cells promote class switching to IgG2c in responding B cells following IAV infection. WT or Cxcr5-/- OT-I cells (or PBS only for no
transfer controls) were transferred i.v. into separate B6.Ifng-/- mice that were then infected with x31-OVA i.n. (A) Schematic outline of the experiment. (B) Gating
strategy used for identification of CD138+B220int ASCs and IgG2c-switching in ASCs in the mLN. Cells in the top panel were pre-gated on live, single cells.
(C) Quantification of ASC number. (D) Frequency of IgG2c+ ASCs among total ASCs. (E) Fold change in IgG2c-induction relative to the no transfer control (dashed
line). (F) Gating strategy used for identification of B220+IgD-GL7+ GCB cells and IgG2c-switching in GCB cells in the mLN. Cells in the top panel were pre-gated on
live, single, B220+CD138- cells. (G) Quantification of GCB cell number. (H) Frequency of IgG2c+ GCB cells among total GCB cells. (I) Fold change in IgG2c-
induction relative to the no transfer control (dashed line). (J) Levels of serum x31-specific IgG2c on day 8 post-infection assessed by ELISA.
(C–E, G–I) Data are pooled from two independent experiments with a total of 7-9 mice group or (J) representative of two independent experiments with 4-5 mice
per group. (C–E, G–I) Data were analysed by ordinary one-way ANOVA or (J) two-way ANOVA with Bonferroni’s multiple comparison test. (C–E, G–I) Mean ± SEM
or (J) Mean + SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.Frontiers in Immunology | www.frontiersin.org July 2021 | Volume 12 | Article 6261999
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CXCR5+CD8+ T cells have been identified in multiple settings,
including tonsils (10, 19), chronic infections [LCMV (11–13), SIV
(35, 36), HIV (11, 37), HBV (17, 38)], cancers [lymphoma (11, 18,
39), colorectal (16, 40), thyroid (41)] and autoimmunity (20, 21,
42). In the present study, we further address questions regarding
the context-specific generation of CXCR5+CD8+ T cells,
demonstrating that, in addition to their existence in response to
chronic stimuli, these cells also arise in acute responses to protein
immunisation and peripheral viral infection where there is an
absence of infection in the follicular microenvironment. In these
settings, CXCR5+CD8+ T cells exhibit limited cytotoxic potential,
display a Tim-3loTCF-1hi signature, indicative of a progenitor-like,
precursor-exhausted CD8+ T cell phenotype, express Tfh-
associated molecules, suggesting they co-opt the follicular
differentiation program, and shape class switching in responding
B cells in vivo, promoting class switching to IgG2c.
Antigen-specific CD8+ T (OT-I) cells upregulated CXCR5 in
response to protein immunisation and IAV. However, the
proportion of host CD44hiCD8+ T cells expressing CXCR5 was
significantly higher than that of the OT-I cells in both models.
Additionally, we have also observed CD44hiCXCR5+CD8+ T cells
in unchallenged mice (data not shown). Therefore, it is likely that
the host CD44hiCXCR5+CD8+ T cells represent endogenous
memory and virtual memory CD8+ T cells, of which we and
others have observed to express CXCR5 [(43) & data not shown].
While CXCR5+CD8+ T (OT-I) cells were generated in both
models, the frequency of OT-I cells expressing CXCR5 was
greater in response to protein immunisation compared to IAV.
This is likely due to differences in the inflammatory milieu induced
by protein immunisation compared with that of a complex pathogen
in IAV. In support of this, CXCR5+CD8+ T cells generated in
response to the more inflammatory IAV express more IFNg, TNFa
and GzmB compared to those generated in response to the less
inflammatory protein immunisation. Indeed, the proinflammatory
cytokine IL-2, which is abundantly expressed in response to IAV, has
been identified in recent studies as a negative regulator of
CXCR5+CD8+ T cell generation. Interrupting the IL-2 signalling
pathway at various levels through deficiency in IL-2 (20), STAT5
(21) and Blimp1 (11) increases differentiation of CXCR5+CD8+ T
cells. Furthermore, IL-2 has been shown to supress the follicular
differentiation pathway and generation of CXCR5+CD4+ T follicular
helper (44) and follicular regulatory cells (45). Therefore, differing
levels of IL-2 in the priming microenvironment present in OVA/
alum and IAV may contribute to regulating the differential
generation of CXCR5+CD8+ T cells. However, further study is
required to determine the factors that influence CXCR5+CD8+ T
cell differentiation in diverse settings.
CXCR5+CD8+ T cells generated in chronic inflammatory
settings are recognised as a distinct CD8+ T cell subset (46, 47).
Here, we demonstrate that CXCR5+CD8+ T cells generated in
response to both protein immunisation and IAV were enriched for
early effector cells, exhibited lower expression of effector molecules
and displayed a Tim-3loTCF-1hi signature which has been
associated with CD8+ T cells that possess greater memoryFrontiers in Immunology | www.frontiersin.org 10potential (48, 49). Further profiling revealed that CXCR5+CD8+
T cells display increased expression of Tfh-associated molecules
including, ICOS, BTLA and Ly108, in both models. Indeed, more
extensive characterisation of CXCR5+CD8+ T cells in LCMV
infection, through RNA sequencing, revealed that they actively
co-opt the follicular differentiation program and express a Tfh-
associated gene signature, including increased expression of ICOS
and Ly108 (11, 12). Thus, CXCR5+CD8+ T cells likely also co-opt
the follicular differentiation program and localise toward B cell
follicles following protein immunisation and IAV. Together, the
results demonstrate that CXCR5+CD8+ T cells generated in
response to protein immunisation and IAV represent a distinct,
specialised population of effector CD8+ T cells and reflect the
characteristics of CXCR5+CD8+ T cells identified early during
chronic infections.
In line with exhibiting a less-exhausted effector cell phenotype
with memory-like potential in response to protein immunisation
and IAV, CXCR5+CD8+ T cells displayed limited cytotoxic
potential as they expressed significantly reduced levels of the
cytolytic molecule GzmB and demonstrated reduced ex vivo
killing activity compared to their CXCR5- counterparts. These
results are consistent with previous findings on the cytotoxic
capacity of CXCR5+CD8+ T cells in chronic LCMV (11). In
contrast, He and colleagues (12) reported that CXCR5+CD8+ T
cells in chronic LCMV possessed greater cytotoxic activity in an
in vivo killing assay. Our data and the results from the study by
Leong and colleagues are from experiments that assessed the
cytotoxicity of CXCR5+CD8+ T cells relatively early, at days 7-8
post-immunisation/infection, while He and colleagues
performed these analyses on cells obtained 21 days post-
infection. Indeed, the profiling data from the study by He and
colleagues also demonstrate that the CXCR5+CD8+ T cells
isolated from later time points express more IFNg and TNFa
compared to their CXCR5- counterparts, while they observed
similar frequencies of cytokine-producing cells at day 8 post-
infection, indicating both CXCR5+ and CXCR5- CD8+ T cells
late during chronic infection are phenotypically distinct from
early cells and therefore likely differ functionally. At late time
points during chronic infection, CXCR5-CD8+ T cells exhibit an
exhausted CD8+ T cell phenotype while CXCR5+CD8+ T cells
retain their proliferative and differentiation potential and can
give rise to functional cytotoxic effector cells (13). These factors
may account for the observed differences in cytotoxic activity
between studies. Together, under the conditions tested, the
results indicate that CXCR5+CD8+ T cells generated in
response to protein immunisation and IAV have reduced
cytotoxic potential, lending support to the notion of
functionality outside of cytotoxicity in these settings.
Despite the majority of work exploring CXCR5+CD8+ T cell
biology focusing on describing their cytotoxic roles during chronic
inflammation in persistent infections and cancers, CD8+ T cells
have been reported to localise within or directly adjacent to B cell
areas of lymphoid tissues (50), yet the significance of this
phenomenon is not understood. Intriguingly, a seminal study in
2007 describing CXCR5+CD8+ T cells in human tonsils, identified
their capacity to support B cell survival and antibody productionJuly 2021 | Volume 12 | Article 626199
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CXCR5+CD8+ T cells can provide help for B cells in in vitro co-
cultures (17–19). Furthermore, in settings where CXCR5+CD8+ T
cell differentiation is exacerbated through interrupting IL-2
signalling, there is an associated increase in autoimmune
antibody responses, indicating that CXCR5+CD8+ T cells can
also promote self-reactive humoral immune responses (20, 21).
In addition to their B cell helper activity, there are also reports of a
specific population of Qa-1-restricted CD8+ T cells that adopt a
follicular T cell phenotype, marked by CXCR5 expression, localise
to B cell follicles and suppress autoreactive GCs through engaging
and inhibiting Tfh cells in a Qa-1-dependent manner (42). Thus,
the function of CXCR5+CD8+ T cells in humoral immunity is
complex and appears to be highly context-dependent.
Here, we demonstrate that in response to protein
immunisation and peripheral viral infection, CXCR5+CD8+ T
cells shape the antibody response in vivo. CXCR5 expression is
required on CD8+ T cells to promote class switching to IgG2c in
responding B cells, likely through CXCR5-mediated local
delivery of IFNg to activated B cells at the T-B border. Indeed,
our data show that the CXCR5+CD8+ T cell-mediated IgG2c
class switching in the ASC compartment in OVA/alum is
independent of changes in IFNg secretion by responding CD4+
T cells and we also did not observe any changes in the total
number of ASCs. This is in contrast to previous reports which
proposed that these effects were indirect, where OT-I cells
amplify IFNg production in the CD4+ T cell compartment
during the response to OVA/alum, leading to increased IgG2c-
switching in the ASC compartment (24). In the present study,
10-fold fewer OT-I cells were adoptively transferred and there
was no cotransfer of CD4+ OT-II cells, technical differences
which may account for the different outcomes. Interestingly,
when production of IFNg is restricted to transferred CD8+ T cells
(OT-I), CXCR5+CD8+ T cells also promote class switching to
IgG2c in both the early GC and ASC compartments in response
to IAV. Recently, Roco and colleagues reported that class switching
events in B cells occur predominantly outside of the GC, in early
antigen-activated B cells at the T-B border (51). Therefore,
CXCR5+CD8+ T cells likely shape class switching in early
activated B cells at the T-B border, while they may also
contribute to regulating this process in committed GCB cells.
Together, the results demonstrate that CXCR5+CD8+ T cells
shape antibody responses in vivo, extending in vitro findings that
indicate CXCR5+CD8+ T cells support B cell survival and antibody
production (10, 17–21). However, further investigations are
required to determine the mechanisms involved in communication
between CXCR5+CD8+ T cells and B cells.
An important outstanding question from this study is where
CXCR5+CD8+ T cells generated in response to protein
immunisation and IAV are localising within the secondary
lymphoid tissue microenvironment. Indeed, CXCR5 is well
recognised for mediating immune cell homing to B cell follicles
(4, 52, 53). CD4+ T cells are known to upregulate CXCR5 during
the early stages of activation following immunisation (4, 54), and
this is critical for directing their migration to the T-B border and
B cell follicles (4). CXCR5 has also been implicated in directingFrontiers in Immunology | www.frontiersin.org 11follicular migration of CD8+ T cells. Elegant in situ imaging
experiments tracking the endogenous tetramer-specific CD8+ T
cell response to Listeria monocytogenes (Lm)-OVA observed
antigen-specific CD8+ T cells localising to the T-B border during
the response (50). In support of these observations, a recent
study found that OT-I cells responding to Lm-OVA upregulate
CXCR5 and localise to the T-B border (55). Furthermore, studies
in the LCMV model comparing follicular-homing of WT and
Cxcr5-/- (11) or sort-transferred CXCR5+ and CXCR5- CD8+ T
cells (12) have demonstrated that CD8+ T cells require CXCR5
expression to migrate to B cell follicles. In contrast to these
reports detailing the essential role of CXCR5 in directing the
follicular-homing of T cells, recent studies have demonstrated
that CD4+ regulatory and helper T cell populations can localise
to B cell follicles independently of CXCR5 expression (56, 57).
Vanderleyden and colleagues found that CXCR5-deficient T
follicular regulatory cells could still infiltrate GCs and B cell
follicles, although their ability to do so was impaired in the
absence of CXCR5 (56). Moreover, Greczmiel and colleagues
demonstrated that CXCR5-deficient Tfh cells can migrate to GCs
and B cell follicles, although the polarity of their distribution
within the GC niche is disrupted in the absence of CXCR5 (57).
Thus, the role of CXCR5 in directing follicular-homing of T cells
appears to be context dependent. As CXCR5+CD8+ T cells have
been shown to utilise CXCR5 to localise to B cell follicles in
response to LCMV infection (11, 12), it is possible they also
employ CXCR5-directed migration to localise to the follicular
microenvironment during the response to protein immunisation
and IAV infection. However, imaging studies are required to
determine the positioning of CXCR5+CD8+ T cells generated in
the latter contexts.
While we have demonstrated that CXCR5+CD8+ T cells
influence physiological B cell responses in the secondary
lymphoid tissue microenvironment of the lymph node, CD8+ T
cells are known to support B cells in ectopic sites. Of note, Yang and
colleagues reported that a population of IL-6-stimulated CD8+ T
cells can provide IL-21 to support antibody production and ectopic
B cell responses in inducible bronchus associated lymphoid tissue
(iBALT) following IAV infection (58). IL-21 production by CD8+ T
cells was restricted to the IL-6-rich lung microenvironment and
absent in CD8+ T cells from the spleen and lymph nodes.
Additionally, CD8+ T cells were found in close contact with GCB
cells within iBALT at 14 days post infection (58). Furthermore,
CD40L-expressing CD8+ T cells have been detected in follicles of
ectopic lymphoid tissue in the synovium from patients with
rheumatoid synovitis and their numbers positively correlated with
the presence of ectopic GCs (59). However, these reports did not
determine whether CXCR5 expression was a feature of IL-21- or
CD40L-expressing CD8+ T cells. Together, these reports
demonstrate that CD8+ T cells can support ectopic humoral
immunity in both physiological and autoimmune settings. In the
present study, we directly implicate CXCR5 expression by CD8+ T
cells in their ability to shape class switching in physiological B cell
responses within secondary lymphoid tissues, supporting the direct
involvement of CXCR5+CD8+ T cells in autoimmune B cell
responses (20, 21). Thus, it will be important to assess whetherJuly 2021 | Volume 12 | Article 626199
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determine how their role in humoral immunity may be
manipulated to assist physiological responses while inhibiting
their contributions to autoimmunity in both secondary and
tertiary lymphoid tissues.
Overall, the findings from this study provide important
insights into the context-specific biology of CXCR5+CD8+ T
cells. Firstly, we show that CXCR5+CD8+ T cells are generated in
vivo in acute responses to protein immunisation and peripheral
viral infection, settings where there is no infection in the
follicular microenvironment. In these contexts, CXCR5+CD8+
T cells display Tfh-like characteristics, indicative of co-option of
the follicular differentiation pathway, exhibit reduced cytotoxic
potential and possess a precursor-exhausted phenotype, features
that also reflect the biology of CXCR5+CD8+ T cells identified in
chronic settings in response to LCMV. Secondly, in addition to
their described cytotoxic roles, we demonstrate that
CXCR5+CD8+ T cells influence humoral immunity, shaping
the antibody response in vivo following protein immunisation
and peripheral viral infection, promoting class switching to
IgG2c in responding B cells, a process dependent on
expression of CXCR5. CXCR5+CD8+ T cell-mediated shaping
of humoral immunity may impart the antibody response with
the required class switched repertoire necessary for effective host
defence, particularly where there is limited CD4+ T cell
capability, such as that observed in later stages of HIV infection.DATA AVAILABILITY STATEMENT
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Supplementary Figure 1 | Data relating to Figures 2–5. (A) Gating strategy
used to define TFH (CXCR5hiPD-1hi) and Pre-TFH (CXCR5midPD-1mid) populations
in the spleen in response to OVA-alum (left) and the mLN in response to x31-OVA
(right). (B-H) Congenically marked WT (CD45.1/2) and Cxcr5-/- (CD45.2) OT-I cells
(or PBS only for no transfer controls) were transferred i.v into separate B6.Ly5.1
(CD45.1) mice that were subsequently immunised with OVA/alum i.p and harvested
on day 7 post-immunisation for analysis. (B) Frequency, (C) total number and
(D) proportion expressing IFNg following re-stimulation of TFH cells. (E) Proportion
and (F) number of Th1 cells following re-stimulation. (G) Total number and (H)
proportion expressing IFNg of WT and Cxcr5-/- OT-I cells. (I-K) C57BL/6 mice were
treated i.p. with either aCD8b or control antibody 4 days before and on day 4 and
12 after i.n infection with x31 and harvested on day 14 post-infection. (I) Levels
of serum x31-specific IgG2c assessed by ELISA. (J) Total number of GCB cells
and (K) number of IgG2c+ GCB cells in the mLNs of mice. (L-N)WT or Cxcr5-/- OT-I
cells (or PBS only for no transfer controls) were transferred i.v. into separate
B6.Ifng-/- mice that were then infected with x31-OVA i.n. (L)Gating strategy used to
identify IFNg-producing CD8+ T cells (OT-I) following re-stimulation. (M) Frequency
and (N) total number of IFNg-producing CD8+ T cells (OT-I). (B-F) Data are pooled
from two independent experiments with a total of 10-12 mice per group. (G) Data
are pooled from two independent experiments with a total of 8-9 mice per group.
(H) Data are representative of two independent experiments, 4 mice per group.
(I-K) Data are pooled from two independent experiments with a total of 9 mice per
group and the absorbance values for the ELISA data have been normalised to the
average of the Ctrl group for each independent experiment prior to pooling the data.
(L-N) Data are representative of two independent experiments, 4-5 mice per group.
(B-F) Data were analysed by ordinary one-way ANOVA, (G, H, J, K, M, N) unpaired
t-tests or (I) two-way ANOVA with Bonferroni’s multiple comparison test. (B-H, J,
K, M, N) Mean ± SEM, (I) Mean + SD.REFERENCES
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